Case Study Biodimed
Support for a Biotech Company entering the french market with an orphan drug.
Support for a Biotech Company entering the french market with an orphan drug.
Cases
Case Study FIECON
Driving a >£1M ICER for a severe and debilitating rare disease to acceptable levels for reimbursement in England and Wales.
Case Study Health Access Agency
Market Access Sweden for prescription and hospital drugs.
Case Study Omakase
Multi-Criteria Decision Analysis (MCDA)
We are pioneers in the utilisation of Multi-Criteria Decision Analysis (MCDA) at international and national level, helping evaluation committees to assess the relative additional value contribution of new health technology and helping companies to better position their product with respect to existing alternatives.
Case Study RPN
Regulatory Pharma Net
RPN has experience with a wide range of therapeutic areas and particularly with orphan and advanced-therapy medicinal products. RPN support includes early access and P&MA strategic assessments, advisory boards, stakeholder management and full support with national and regional P&R negotiations.
Case Study SmartStep Consulting
Be prepared.
SmartStep Healthcare Strategy & Market Access Consulting provides personalized and specialized consulting services to the pharmaceutical and medical device industries to provide fast and effective market access to their products in Germany.